Spyglass Pharma Inc (SGP)

Finanzdaten der Spyglass Pharma Inc-Aktie (SGP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2009-12-31	2009-09-30	2009-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	42.56%21.97	15.41	-	-	-
Research and Development	28.10%10.94	8.54	-	-	-
Operating Income/Loss	42.56%-21.97	-15.41	-	-	-
Nonoperating Income/Loss	32.18%2.10	1.59	-	-	-
Income/Loss From Continuing Operations Before Tax	43.75%-19.86	-13.82	13,889.30	4,499.00	4,647.00
Income Tax Expense/Benefit	-	-	1,939.60	97.00	102.00
	43.75%-19.86	-13.82	11,033.20	515.00	671.00
Attributable To Parent	43.75%-19.86	-13.82	10,910.30	515.00	671.00
Basic Average Shares	67.80%33.44	19.93	-	-	-
Diluted Average Shares	67.80%33.44	19.93	-	-	-
Basic Earnings Per Share	14.49%-0.59	-0.69	4.53	0.29	0.38
Diluted Earnings Per Share	14.49%-0.59	-0.69	4.52	0.29	0.38